乳腺癌治疗中的心脏毒性:原因和缓解
Deepthi Valiyaveettil1, Deepa Joseph2, Monica Malik1
1Nizam's Institute of Medical sciences, Hyderabad, India.
Cancer treatment and research communications
|September 15, 2023
概括
改善的乳腺癌治疗方法增加了生存率,但也导致心脏毒性. 本综述检查了心脏毒剂,并建议乳腺癌幸存者的后续策略,以减轻心脏损伤和改善生活质量.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 癌症的生存率 癌症的生存率
背景情况:
- 改善的乳腺癌疗法导致患者的生存率增加.
- 心脏毒性是乳腺癌患者治疗相关的重大副作用.
- 心脏毒性的全部程度及其对幸存者的生活质量的影响仍然不完全理解.
研究的目的:
- 审查乳腺癌患者中引起心脏毒性的药物.
- 为乳腺癌幸存者提出后续战略.
- 为了减少心脏毒性对幸存者的生活质量的影响.
主要方法:
- 对乳腺癌治疗中使用的心脏毒剂的文献综述.
- 对乳腺癌幸存者的当前随访协议的分析.
- 拟议后续行动框架的制定.
主要成果:
- 确定了与心脏毒性相关的关键治疗剂.
- 突出了当前研究和心脏毒性管理的局限性.
- 概述了一种结构化的方法,用于监测和管理幸存者的心脏毒性.
结论:
- 心脏毒性是乳腺癌存活率的一个关键问题.
- 进一步的研究和标准化的后续协议是必不可少的.
- 主动管理可以改善乳腺癌幸存者的长期结果和生活质量.
相关概念视频
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure Drugs: Inotropic Agents
617
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
617
Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
460
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
460
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


